GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (WBO:ALM) » Definitions » Cyclically Adjusted Price-to-FCF

Almirall (WBO:ALM) Cyclically Adjusted Price-to-FCF : 19.04 (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Almirall Cyclically Adjusted Price-to-FCF?

As of today (2024-06-08), Almirall's current share price is €9.33. Almirall's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.49. Almirall's Cyclically Adjusted Price-to-FCF for today is 19.04.

The historical rank and industry rank for Almirall's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

WBO:ALM' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 8.09   Med: 20.66   Max: 31.81
Current: 18.92

During the past years, Almirall's highest Cyclically Adjusted Price-to-FCF was 31.81. The lowest was 8.09. And the median was 20.66.

WBO:ALM's Cyclically Adjusted Price-to-FCF is ranked better than
68.63% of 322 companies
in the Drug Manufacturers industry
Industry Median: 31.865 vs WBO:ALM: 18.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Almirall's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €0.033. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.49 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Almirall Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Almirall's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Cyclically Adjusted Price-to-FCF Chart

Almirall Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.92 23.42 21.61 - -

Almirall Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 17.49 14.97 - 16.78

Competitive Comparison of Almirall's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almirall's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Almirall's Cyclically Adjusted Price-to-FCF falls into.



Almirall Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Almirall's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=9.33/0.49
=19.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Almirall's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.033/122.7621*122.7621
=0.033

Current CPI (Mar. 2024) = 122.7621.

Almirall Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 0.095 101.306 0.115
201403 -0.148 100.139 -0.181
201406 -0.063 101.081 -0.077
201409 0.354 100.441 0.433
201412 3.401 100.251 4.165
201503 0.601 99.474 0.742
201506 -0.020 101.138 -0.024
201509 0.271 99.559 0.334
201512 0.109 100.268 0.133
201603 0.270 98.638 0.336
201606 -0.018 100.333 -0.022
201609 0.499 99.737 0.614
201612 -0.572 101.842 -0.689
201703 -0.273 100.896 -0.332
201706 -0.311 101.848 -0.375
201709 0.143 101.524 0.173
201712 0.079 102.975 0.094
201803 0.187 102.122 0.225
201806 -0.345 104.165 -0.407
201809 0.691 103.818 0.817
201812 -3.148 104.193 -3.709
201903 0.142 103.488 0.168
201906 0.196 104.612 0.230
201909 0.450 103.905 0.532
201912 0.020 105.015 0.023
202003 0.241 103.469 0.286
202006 -0.429 104.254 -0.505
202009 0.310 103.521 0.368
202012 0.084 104.456 0.099
202103 0.424 104.857 0.496
202106 0.003 107.102 0.003
202109 0.338 107.669 0.385
202112 0.145 111.298 0.160
202203 -0.051 115.153 -0.054
202206 0.115 118.044 0.120
202212 0.000 117.650 0.000
202303 -0.058 118.948 -0.060
202306 0.031 120.278 0.032
202312 0.000 121.300 0.000
202403 0.033 122.762 0.033

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Almirall  (WBO:ALM) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Almirall Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Almirall's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Almirall (WBO:ALM) Business Description

Industry
Traded in Other Exchanges
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (WBO:ALM) Headlines

From GuruFocus

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar 05-07-2021

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar 06-02-2021